A comparison between the Farr radioimmunoassay and a new automated fluorescence immunoassay for the detection of antibodies against double stranded DNA in serum - PubMed (original) (raw)
Comparative Study
A comparison between the Farr radioimmunoassay and a new automated fluorescence immunoassay for the detection of antibodies against double stranded DNA in serum
R H W M Derksen et al. Ann Rheum Dis. 2002 Dec.
Abstract
Objective: To compare test characteristics of the Farr radioimmunoassay and an automated fluorescence immunoassay (ELIA dsDNA test) for the diagnosis of systemic lupus erythematosus (SLE).
Methods: A cross sectional study comprising 440 samples from 440 patients, sent to the laboratory over a three month period for anti-dsDNA testing. Chart review was performed, blinded for test results, to count for each patient the number of American College of Rheumatology criteria for the classification of SLE that were fulfilled. At least four criteria were met by 248 (56%) patients (SLE), one to three criteria by 77 (18%) (lupus-like disease, LLD), and no criterion by 115 (26%) (non-SLE/non-LLD). Results from serum samples from the non-SLE/non-LLD and SLE groups were used to calculate receiver operating characteristic curves.
Results: For the Farr assay, specificities of 95% and 99% corresponded to sensitivities of 72% and 56% respectively. For the ELIA dsDNA test these levels of specificity corresponded to sensitivities of 44% and 17% respectively.
Conclusions: The Farr radioimmunoassay is superior to the ELIA dsDNA test for identifying patients with SLE.
Figures
Figure 1
Prevalence of ACR criteria for the classification of systemic lupus erythematosus (SLE) in 77 patients with lupus-like disease (LLD) and 249 patients with SLE. Numbers on the x axis represent individual criteria. 1, Butterfly rash; 2, chronic discoid lupus (CDLE); 3, photosensitivity; 4, oropharyngeal ulcers; 5, arthritis of at least two joints; 6, anti-dsDNA antibodies (any assay, any time); 7, nephritis; 8, serositis; 9, psychosis and/or epilepsy; 10, haemolytic anaemia, leucocytopenia, and/or thrombocytopenia; 11, ANA.
Figure 2
Results with the Farr assay and ELIA dsDNA test in IU/ml for the patients who were non-SLE/non-LLD (n=115, panel A), patients with LLD (n=77, panel B), and those with SLE (n=248, panel C). The results for the Farr assay are shown in panels A, B and C on the y axis; the y axis in panels B and C has a log scale. Panel D depicts the ROC curve for the Farr assay (continuous line) and ELIA dsDNA test (dotted line). Circles 1 and 2 correspond to cut off points for the Farr assay of 6 IU/ml and 12 IU/ml, respectively. These cut off points result in 95% and 99% specificity, respectively. Circles 3 and 4 correspond to cut off points with the ELIA dsDNA test of 19 IU/ml and 84 IU/ml, respectively. These cut off points have a specificity of 95% and 99%, respectively.
Similar articles
- Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE.
Hillebrand JJ, Bernelot Moens HJ, Mulder AH. Hillebrand JJ, et al. Lupus. 2013 Oct;22(11):1169-73. doi: 10.1177/0961203313500368. Epub 2013 Aug 8. Lupus. 2013. PMID: 23929638 - Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
Antico A, Platzgummer S, Bassetti D, Bizzaro N, Tozzoli R, Villalta D; Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine (SIMeL). Antico A, et al. Lupus. 2010 Jul;19(8):906-12. doi: 10.1177/0961203310362995. Epub 2010 Feb 23. Lupus. 2010. PMID: 20179169 - Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease.
de Leeuw K, Bungener L, Roozendaal C, Bootsma H, Stegeman CA. de Leeuw K, et al. Rheumatology (Oxford). 2017 May 1;56(5):698-703. doi: 10.1093/rheumatology/kew462. Rheumatology (Oxford). 2017. PMID: 28053277 - The use of laboratory tests in the diagnosis of SLE.
Egner W. Egner W. J Clin Pathol. 2000 Jun;53(6):424-32. doi: 10.1136/jcp.53.6.424. J Clin Pathol. 2000. PMID: 10911799 Free PMC article. Review. - Laboratory procedures used in the diagnosis of systemic lupus erythematosus: a review.
Gay L, Barr J. Gay L, et al. Am J Med Technol. 1977 Sep;43(9):856-63. Am J Med Technol. 1977. PMID: 73351 Review.
Cited by
- Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings.
Admou B, Eddehbi FE, Elmoumou L, Elmojadili S, Salami A, Oujidi M, Brahim I, Hazime R. Admou B, et al. Pract Lab Med. 2022 Jun 3;31:e00285. doi: 10.1016/j.plabm.2022.e00285. eCollection 2022 Aug. Pract Lab Med. 2022. PMID: 35711387 Free PMC article. - Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Salonen EM, et al. Ann Rheum Dis. 2004 Oct;63(10):1250-4. doi: 10.1136/ard.2003.011890. Ann Rheum Dis. 2004. PMID: 15361381 Free PMC article. - Myth and reality: practical test system for the measurement of anti-DNA antibodies in the diagnosis of systemic lupus erythematosus (SLE).
McCloskey LJ, Christner P, Jacobs-Kosmin D, Jaskowski TD, Hill HR, Lakos G, Teodorescu M. McCloskey LJ, et al. J Clin Lab Anal. 2010;24(2):77-84. doi: 10.1002/jcla.20358. J Clin Lab Anal. 2010. PMID: 20333761 Free PMC article. - Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis.
Rekvig OP. Rekvig OP. Front Immunol. 2020 Oct 6;11:569234. doi: 10.3389/fimmu.2020.569234. eCollection 2020. Front Immunol. 2020. PMID: 33123142 Free PMC article. Review. - Comparison and evaluation of different methodologies and tests for detection of anti-dsDNA antibodies on 889 Slovenian patients' and blood donors' sera.
Zigon P, Lakota K, Cucnik S, Svec T, Ambrozic A, Sodin-Semrl S, Kveder T. Zigon P, et al. Croat Med J. 2011 Dec 15;52(6):694-702. doi: 10.3325/cmj.2011.52.694. Croat Med J. 2011. PMID: 22180268 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous